Derivative Instruments (Tables)

6 Months Ended

Jul. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Outstanding Foreign Exchange Forward Contracts

As of July 30, 2022, the Company had outstanding the following foreign currency exchange forward contracts that were entered into to hedge either a portion, or all, of forecasted foreign-currency-denominated intercompany inventory transactions, the resulting settlement of the foreign-currency-denominated intercompany accounts receivable, or both:

(in thousands)	Notional Amount (1)
Euro	$	35,470
British pound	18,909
Canadian dollar	5,656
Japanese yen	4,383

(1)    Amounts reported are the U.S. Dollar notional amounts outstanding as of July 30, 2022.

Location and Amounts of Derivative Fair Values on the Condensed Consolidated Balance Sheets

The fair value of derivative instruments is valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk. The location and amounts of derivative fair values of foreign currency exchange forward contracts on the Condensed Consolidated Balance Sheets as of July 30, 2022 and January 29, 2022 were as follows:

(in thousands)	Location	July 30, 2022		January 29, 2022		Location	July 30, 2022		January 29, 2022
Derivatives designated as cash flow hedging instruments	Other current assets	$	5,169	$	4,973	Accrued expenses	$	3	$	—
Derivatives not designated as hedging instruments	Other current assets	—		—		Accrued expenses	—		—
Total		$	5,169	$	4,973		$	3	$	—

Location and Amounts of Derivative Gains and Losses on the Condensed Consolidated Statements of Operations and Comprehensive Loss

Information pertaining to derivative gains or losses from foreign currency exchange forward contracts designated as cash flow hedging instruments for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021 follows:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in thousands)	July 30, 2022		July 31, 2021		July 30, 2022		July 31, 2021
Gain recognized in AOCL (1)	$	2,361	$	1,084	$	7,724	$	2,228
Gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization (2)	4,124		(1,697)		$	7,809	$	(3,152)

(1)Amount represents the change in fair value of derivative instruments.

(2)Amount represents gain (loss) reclassified from AOCL to cost of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) when the hedged item affects earnings, which is when merchandise is converted to cost of sales, exclusive of depreciation and amortization.

Substantially all of the unrealized gain will be recognized in costs of sales, exclusive of depreciation and amortization, on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income over the next twelve months.

Additional information pertaining to derivative gains or losses from foreign currency exchange forward contracts not designated as hedging instruments for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021 follows:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in thousands)	July 30, 2022		July 31, 2021		July 30, 2022		July 31, 2021
Gain (loss) recognized in other operating income, net	$	631	$	304	$	1,772	$	(164)